Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 124105, 9 pages
http://dx.doi.org/10.1155/2014/124105
Research Article

ErbB4 as a Potential Molecular Target in the Treatment of Esophageal Squamous Cell Cancers

Department of Thoracic Surgery, The Central Hospital of Wuhan, Jiang’an District, Wuhan, Hubei 430014, China

Received 8 May 2014; Accepted 29 July 2014; Published 4 November 2014

Academic Editor: Qinghua Cui

Copyright © 2014 Ke Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA: Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. M. Shahbaz Sarwar, J. D. Luketich, R. J. Landreneau, and G. Abbas, “Esophageal cancer: an update,” International Journal of Surgery, vol. 8, no. 6, pp. 417–422, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA: A Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W.-Q. Chen, R.-S. Zheng, S.-W. Zhang et al., “Report of incidence and mortality in china cancer registries, 2008,” Chinese Journal of Cancer Research, vol. 24, no. 3, pp. 171–180, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Liu, R. Li, Z. Zhu et al., “Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles,” International Journal of Pharmaceutics, vol. 430, no. 1-2, pp. 350–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Allgayer and S. Fulda, “An introduction to molecular targeted therapy of cancer,” Advances in Medical Sciences, vol. 53, no. 2, pp. 130–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. V. Bachawal, V. B. Wali, and P. W. Sylvester, “Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells,” BMC Cancer, vol. 10, article 84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. W. P. Tew, D. P. Kelsen, and D. H. Ilson, “Targeted therapies for esophageal cancer,” Oncologist, vol. 10, no. 8, pp. 590–601, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Wieduwilt and M. M. Moasser, “The epidermal growth factor receptor family: biology driving targeted therapeutics,” Cellular and Molecular Life Sciences, vol. 65, no. 10, pp. 1566–1584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Yarden and G. Pines, “The ERBB network: at last, cancer therapy meets systems biology,” Nature Reviews Cancer, vol. 12, no. 8, pp. 553–563, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. N. E. Hynes and H. A. Lane, “ERBB receptors and cancer: the complexity of targeted inhibitors,” Nature Reviews Cancer, vol. 5, no. 5, pp. 341–354, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Gilmour, K. Macleod, A. McCaig, W. Gullick, J. Smyth, and S. Langdon, “Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer,” Cancer Research, vol. 61, no. 5, pp. 2169–2176, 2001. View at Google Scholar · View at Scopus
  13. K. D. Steffensen, M. Waldstrøom, R. F. Andersen et al., “Protein levels and gene expressions of the epidermal growth factor receptors, HER1,H ER2, HER3 and HER4 in benign and malignant ovarian tumors,” International Journal of Oncology, vol. 33, no. 1, pp. 195–204, 2008. View at Google Scholar · View at Scopus
  14. T. Pejovic, N. T. Pande, M. Mori et al., “Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes,” Translational Oncology, vol. 2, no. 4, pp. 341–349, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Campiglio, S. Ali, P. Knyazev, and A. Ullrich, “Characteristics of EGFR family-mediated HRG signals in human ovarian cancer,” Journal of Cellular Biochemistry, vol. 73, no. 4, pp. 522–532, 1999. View at Google Scholar
  16. S. Xu, J. Kitayama, H. Yamashita, D. Souma, and H. Nagawa, “Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma,” Journal of Surgical Oncology, vol. 97, no. 1, pp. 44–50, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Pang, H. Fan, and D. Ge, “Effect of down-regulating HER4 gene on migration and invasion of esophageal carcinoma cell line Eca-109,” Fudan University Journal of Medical Sciences, vol. 35, no. 4, pp. 521–527, 2008. View at Google Scholar · View at Scopus
  18. V. Kainulainen, M. Sundvall, J. A. Määttä, E. Santiestevan, M. Klagsbrun, and K. Elenius, “A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis,” The Journal of Biological Chemistry, vol. 275, no. 12, pp. 8641–8649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Sepp-Lorenzino, I. Eberhard, Z. Ma et al., “Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells,” Oncogene, vol. 12, no. 8, pp. 1679–1687, 1996. View at Google Scholar · View at Scopus
  20. D. A. Kerr II and J. L. Wittliff, “A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen,” Hormones and Cancer, vol. 2, no. 5, pp. 261–271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, “The impact of microRNAs on protein output,” Nature, vol. 455, no. 7209, pp. 64–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Garzon, G. A. Calin, and C. M. Croce, “MicroRNAs in cancer,” Annual Review of Medicine, vol. 60, pp. 167–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. V. Iorio, R. Visone, G. Di Leva et al., “MicroRNA signatures in human ovarian cancer,” Cancer Research, vol. 67, no. 18, pp. 8699–8707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. J. Nam, H. Yoon, S. W. Kim et al., “MicroRNA expression profiles in serous ovarian carcinoma,” Clinical Cancer Research, vol. 14, no. 9, pp. 2690–2695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Merimsky, A. Staroselsky, M. Inbar et al., “Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer,” Annals of Oncology, vol. 12, no. 8, pp. 1127–1131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Srinivasan, C. E. Gillett, D. M. Barnes, and W. J. Gullick, “Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers,” Cancer Research, vol. 60, no. 6, pp. 1483–1487, 2000. View at Google Scholar · View at Scopus
  29. D. R. F. Haugen, L. A. Akslen, J. E. Varhaug, and J. R. Lillehaug, “Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas,” Cancer Research, vol. 56, no. 6, pp. 1184–1188, 1996. View at Google Scholar · View at Scopus
  30. T. D. Prickett, N. S. Agrawal, X. Wei et al., “Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4,” Nature Genetics, vol. 41, no. 10, pp. 1127–1132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-Y. Ni, M. P. Murphy, T. E. Golde, and G. Carpenter, “γ-Secretase cleavage and nuclear locatization of ErbB-4 receptor tyrosine kinase,” Science, vol. 294, no. 5549, pp. 2179–2181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Minko, E. V. Batrakova, S. Li et al., “Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells,” Journal of Controlled Release, vol. 105, no. 3, pp. 269–278, 2005. View at Publisher · View at Google Scholar · View at Scopus